<noscript id="o600k"></noscript>

<ins id="o600k"><acronym id="o600k"></acronym></ins>
<small id="o600k"></small>
<tr id="o600k"><track id="o600k"></track></tr>
    <tr id="o600k"></tr>
    1. <output id="o600k"></output>
      <ins id="o600k"><video id="o600k"></video></ins>
      <tr id="o600k"><nobr id="o600k"><delect id="o600k"></delect></nobr></tr>

    2. <menuitem id="o600k"></menuitem><sup id="o600k"><track id="o600k"></track></sup>

    3. <noscript id="o600k"><nobr id="o600k"></nobr></noscript>

    4. <tr id="o600k"><small id="o600k"><acronym id="o600k"></acronym></small></tr>
      1. <sup id="o600k"></sup>

      2. <output id="o600k"><nobr id="o600k"></nobr></output>
          <tr id="o600k"><small id="o600k"><acronym id="o600k"></acronym></small></tr>

          <code id="o600k"></code>

          <tr id="o600k"></tr>
        1. <small id="o600k"></small>
          <menuitem id="o600k"></menuitem>
          
        2. <tr id="o600k"></tr>
            1. <menuitem id="o600k"><video id="o600k"></video></menuitem>
              <sup id="o600k"><track id="o600k"></track></sup>
            2. Transcatheter heart valve product candidates
              The product which is interventive, minimally invasive, without surgical sutures and cardiopulmonary bypass is used to replace the diseased valve. This new designed product can simplify the replacement surgery, significantly reducing the risks of treatment and increasing success rate. Moreover, this can shorten patients’ postoperative recovery time and cut down costs. Furthermore, reduced price of similar products enables more patients to have opportunities to endure risk and expense of surgery and treatment. As a revolutionary treatment, transcatheter artificial heart valve prosthesis is being well recognized by experts. In the future, clinical demands will grow explosively.
              人工心臟瓣膜及導管植入系統
              人工心臟瓣膜及導管植入系統具有介入、無手術縫線、無需體外循環和無須開胸手術等特點,用于置換心臟內病變的瓣膜。這種新型產品將使心臟瓣膜置換手術過程簡化、治療風險大幅降低、成功率將顯著提高,同時也將縮短病人術后恢復時間及大大降低費用,拉低進口同類產品價格,使更多的病人能夠承受手術的風險和費用而得到治療。介入人工心臟瓣膜作為一種革命性的治療手段,正日益被專家所認同,在可預見的未來幾年內,臨床需求將會呈現爆發性的增長。紐脈醫療已組建全面的經導管置換和修復在研產品組合,用于治療人類心臟中的所有四個瓣膜,連同用于介入心臟手術的附件。目前,我們的產品研發管線包括16樣在研產品,國家藥監局已認可我們的三樣在研產品為符合特別審查資格的創新醫療器械。
              久久国产乱子伦精品免费女 玩朋友的丰满人妻| 丝瓜app| 波多野结衣加勒比| 免费视频网| 国产三级视频在线观看视| 从邪恶中拯救我| 真白萌| 亚洲线精品一区二区三区| 99热成人精品热久久6| 一道久在线无码加勒比| 717理论片午影院无码爱恋|